United States· US:68999-841_46dc543c-d51b-4dee-e063-6394a90a1856
Oxcarbazepine
A oxcarbazepine product containing oxcarbazepine, registered in United States by Chartwell Governmental & Specialty RX, LLC.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Oxcarbazepine is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AF02 (oxcarbazepine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Oxcarbazepine · ATC N03AF02
15 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of oxcarbazepine costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $0.56 in United States to $2.54 in Switzerland — a ×4.5 gap.
- United States: $0.56 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Oxcarbazepine · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.54
- FR France$1.08
- IT Italy$0.73
- US United States$0.56 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OXCARBAZEPINE
- Manufacturer
- Chartwell Governmental & Specialty RX, LLC.
- Country
- United States (US)
- ATC code
- N03AF02
- ATC class
- Oxcarbazepine
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168999-841-24
- ndc1168999841242 TRAY in 1 BOX (68999-841-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-841-45)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
398 interactions on record for oxcarbazepine.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxcarbazepine · interactions on record
398 records
- 8 severe
- 263 moderate
- 7 minor
- 72 info
Most severe, free to view
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- EthinylestradiolG03CA01severe
48 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxcarbazepine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenTrileptal 60 mg/ml Oral suspensionEbb Medical AB
- NetherlandsTrileptal 60 mg/ml, suspensie voor oraal gebruikMedcor Pharmaceuticals B.V.
- NorwayTrileptalNovartis Norge (2)
- IrelandTrileptal 60 mg/ml oral suspensionPCO Manufacturing Ltd.
- PolandTrileptalNovartis Poland Sp. z o.o.
- IcelandTrileptalNovartis Healthcare A/S
- SpainTRILEPTAL 60 mg/ml SUSPENSION ORALNovartis Farmaceutica S.A.
- FinlandTrileptalNovartis Finland Oy
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Trileptal
- Belgium · Oxcarbazepine Viatris, Trileptal
- Bulgaria · Трилептал
- Cyprus · Oxcarbazepine Jubilant, Trileptal
- Germany · Apydan Extent, Oxcarbazepin 1 A Pharma
- Denmark · Apydan, Oxcarbazepin Jubilant
- Estonia · Apydan, Trileptal
- Spain · Oxcarbazepina Cinfa, Oxcarbazepina Normon
- Finland · Apydan, Oxcarbazepin Orion
- France · Oxcarbazepine Sandoz, Oxcarbazepine Viatris
- United Kingdom (Northern Ireland) · Oxcarbazepine, Oxcarbazepine Amarox
- Greece · Trileptal
- Croatia · Trileptal
- Hungary · Trileptal
- Ireland · Trileptal
- Iceland · Oxcarbazepine Jubilant, Trileptal
- Italy · Oxcarbazepina Tecnigen, Tolep
- Lithuania · Trileptal
- Latvia · Trileptal
- Netherlands · Oxcarbazepine Adoh, Oxcarbazepine Jubilant
- Norway · Trileptal
- Poland · Karbagen, Oxepilax
- Portugal · Epilfarmo, Oxcarbazepina Biofarmoz
- Romania · Trileptal
- Sweden · Trileptal
- Slovenia · Karbox
- Slovakia · Trileptal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9c5e825-23e0-4bdf-9b09-5965c99d7b2e GET /v1/drugs/c9c5e825-23e0-4bdf-9b09-5965c99d7b2e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "300",
"substance": "OXCARBAZEPINE",
"productndc": "68999-841",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/5mL",
"application_number": "ANDA212428",
"marketing_category": "ANDA"
}See everything about oxcarbazepine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.